No. There was wording in the Attorney scrubbed Berkeley Bio Facebook post that made me feel like the (notably) high number of Dharma patients that they have been treating, get free treatment that's paid for by Yak (SKTO) sales revenue. Somewhere in the future financials I'd expect there to be the incoming revenue from shareholders buying product on PJ, plus buying via the established collective & dispensary sales channel, but cancelled out (in some fancy accounting fashion) by the cost of Dharma to operate. Who knows how the previous fins account for this. This is a guess only as the financials are a shell game and a work of Art, not a work of science or fact, and us amateur attorneys cannot possibly understand. IMO only.

EADIG U2 LS.